Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Powell Says Soft Landing Is Our Goal, Will Be Challenging

-Reuters

byBenzinga Newsdesk

June 22, 2022

1 minute read

-Reuters

Cowen & Co. Initiates Coverage On InnovAge Holding with Market Perform Rating, Announces Price Target of $17

By Benzinga Newsdesk

Today, 6:08 AM

Cowen & Co. analyst Gary Taylor initiates coverage on InnovAge Holding (NASDAQ:INNV) with a Market Perform rating and announces Price Target of $17.

INNV

Paylocity Holding Q4 Adj. EPS $0.32 Beats $0.30 Estimate, Sales $167.50M Beat $162.12M Estimate

By Benzinga Newsdesk

Today, 6:08 AM

Paylocity Holding (NASDAQ:PCTY) reported quarterly earnings of $0.32 per share which beat the analyst consensus estimate of $0.30 by 6.67 percent. This is unchanged from the same period last year. The company reported

PCTY

EF Hutton Initiates Coverage On Glimpse Group with Buy Rating, Announces Price Target of $14

By Benzinga Newsdesk

Today, 6:08 AM

EF Hutton analyst Ben Piggott initiates coverage on Glimpse Group (NASDAQ:VRAR) with a Buy rating and announces Price Target of $14.

VRAR

Oppenheimer Initiates Coverage On Zentalis Pharmaceuticals with Outperform Rating, Announces Price Target of $90

By Benzinga Newsdesk

Today, 6:08 AM

Oppenheimer analyst Matthew Biegler initiates coverage on Zentalis Pharmaceuticals (NASDAQ:ZNTL) with a Outperform rating and announces Price Target of $90.

ZNTL

Powell Says Soft Landing Is Our Goal, Will Be Challenging

Related Posts

Cowen & Co. Initiates Coverage On InnovAge Holding with Market Perform Rating, Announces Price Target of $17

Paylocity Holding Q4 Adj. EPS $0.32 Beats $0.30 Estimate, Sales $167.50M Beat $162.12M Estimate

EF Hutton Initiates Coverage On Glimpse Group with Buy Rating, Announces Price Target of $14

Oppenheimer Initiates Coverage On Zentalis Pharmaceuticals with Outperform Rating, Announces Price Target of $90